Filter
138
Filtered Results: 138
Text search:
genetically
susceptible
Featured
Recommendations
13
New Publications
35
Language
Document type
No document type
63
Guidelines
28
Studies & Reports
26
Manuals
12
Strategic & Response Plan
5
Fact sheets
3
Training Material
1
Countries / Regions
India
9
Kenya
6
Africa
6
Global
5
Latin America and the Carribbean
4
Philippines
3
Western and Central Europe
3
Sierra Leone
2
Syria
2
Tanzania
2
Ethiopia
2
Nepal
1
Nigeria
1
Afghanistan
1
Haiti
1
Asia
1
Germany
1
Congo, Democratic Republic of
1
Middle East and North Africa
1
Latvia
1
South Africa
1
Uganda
1
Russia
1
Namibia
1
Liberia
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
33
Clinical Guidelines
16
Public Health
14
Pharmacy & Technologies
11
Key Resources
6
Capacity Building
3
Women & Child Health
3
Toolboxes
AMR
12
Rapid Response
11
COVID-19
9
NTDs
9
TB
8
Planetary Health
8
Polio
8
Mental Health
7
Ebola
7
NCDs
5
Pharmacy
4
Specific Hazards
2
Refugee
2
HIV
2
Cholera
2
Caregiver
1
Conflict
1
Zika
1
Global Health Education
1
World Drug Report 2018
-4-
Mood disorders
Chapter E.2
Other disorders Chapter H.1
Environmental Pollution
http://dx.doi.org/10.1016/j.envpol.2013.05.046
Accessed Febr. 6, 2020
A role for nuclear techniques
Antimicrobials play a critical role in the treatment of human and animal (aquatic and terrestrial) diseases, which has led to their widespread application and use. Antimicrobial resistance (AMR) is the ability of microorganisms to stop an antibiotic, such as an antimic...
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenges in building national surveillance systems due to ...
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies of Plasmodium falciparum drug resistance, the Report...
This document outlines the evaluation process that WHO undertakes to assess novel tools and strategies targeted at VBDs. Its aim is to articulate the linkage between the generation of evidence that demonstrates public health impact of novel interventions, and the development of policy recommendation...
Infectious diseases cause over one billion human infections per year, with millions of deaths each year globally. Extensive health and financial burden is seen from both established and emerging infectious diseases. Infectious diseases also affect plants and animals, which may pose threats to agricu...
Human use of land has been transforming Earth's ecology for millennia. From hunting and foraging to burning the land to farming to industrial agriculture, increasingly intensive human use of land has reshaped global patterns of biodiversity, ecosystems, landscapes, and climate. This review examines ...
This Commission report aims to contribute to a new era of multilateral cooperation based on strong UN institutions to reduce the dangers of COVID-19, forestall the next pandemic, and enable the world to achieve the agreed goals of sustainable development, human rights, and peace that governments are...
Although Shiga toxin-producing Escherichia coli (STEC) have been isolated from a variety of food production animals, they are most commonly associated with ruminants from which we derive meat and milk. Because of the widespread and diverse nature of ruminant-derived food production, coupled with the...
Pathogens . 2021 Nov 16;10(11):1493.doi: 10.3390/pathogens10111493
.Chronic manifestations of Chagas disease present as disabling and life-threatening condi-tions affecting mainly the cardiovascular and gastrointestinal systems. Although meaningful research has outlined the different molecular mech...
Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. Under natural conditions, the principal transmissio...
Module 10
Testing providers
July 2017
Module 10: Testing providers. This module is for people who provide testing services at PrEP sites and laboratories. It offers guidance in selecting testing services, including screening of individuals before PrEP is initiated and monitoring while they ar...
